SYNDAX PHARMACEUTICALS INC
SNDXNASDAQ🏆 #1999 by market capEarnings Nov 2US Equity
$20.33▲ $0.04 (+0.20%)
Live1h▲ 0.2%
24h▲ 0.2%
7d▲ 2.0%
14d▲ 5.7%
30d▼ 11.2%
1y▲ 56.6%
🏦Market Cap
$1.80B
Small Cap
📈Revenue Growth (YoY)
+222.7%
High Growth
📊Gross Margin
95.8%
High
💵FCF Margin
—
⚖️P/S Ratio
7.2x
Fair
Otter Score
49
Weak
Earnings
Q3 · 2026Reported 2026-08-04Earnings Per Share
Actual
-0.55
Expected
-0.45
miss
−22.90%
YoY +33.70%
Revenue
Actual
$72.79M
Expected
$79.36M
miss
−8.30%
YoY +91.80%
Consensus estimates
Recent quarters
Q3 2026
-0.55
miss
Q2 2026
-0.48
beat
Q1 2026
-0.78
miss
Q4 2025
-0.70
beat